CVS Health Corporation $CVS Position Cut by Asset Management One Co. Ltd.

Key Points

• Asset Management One Co. Ltd. reduced its CVS Health position by 7.7%, selling 59,679 shares and retaining 711,638 shares valued at approximately $61 million. Institutional investors and hedge funds collectively own 80.66% of the company.
• CVS reported quarterly EPS of $2.58, beating estimates of $1.87, while revenue rose 7.3% year over year to $106.1 billion. Management’s fiscal 2026 EPS guidance is $7.90–$8.10.
• The company maintains a quarterly dividend of $0.665, equivalent to a 2.9% annual yield. Analysts remain broadly positive, with a “Moderate Buy” consensus rating and an average price target of $107.80 versus the stock’s reported $91.11 price.

Asset Management One Co. Ltd. lessened its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 7.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 711,638 shares of the pharmacy operator's stock after selling 59,679 shares during the period. Asset Management One Co. Ltd. owned 0.06% of CVS Health worth $60,980,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of CVS. Kilter Group LLC purchased a new stake in CVS Health during the 2nd quarter worth about $27,000. Global Trust Asset Management LLC boosted its stake in shares of CVS Health by 344.8% during the 1st quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator's stock worth $28,000 after purchasing an additional 300 shares during the last quarter. J.Safra Asset Management Corp purchased a new stake in shares of CVS Health during the second quarter worth about $30,000. Beaird Harris Wealth Management LLC grew its holdings in shares of CVS Health by 201.0% during the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator's stock worth $30,000 after buying an additional 195 shares in the last quarter. Finally, Timbuktu Capital Management LLC purchased a new stake in shares of CVS Health during the second quarter worth about $31,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Price Performance

Shares of CVS stock opened at $91.11 on Wednesday. The firm's 50-day simple moving average is $91.46 and its 200-day simple moving average is $88.62. CVS Health Corporation has a 1-year low of $69.51 and a 1-year high of $110.68. The firm has a market cap of $116.53 billion, a P/E ratio of 24.10 and a beta of 0.60.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.87 by $0.71. The company had revenue of $106.10 billion during the quarter, compared to analysts' expectations of $100.03 billion. During the same quarter in the previous year, the firm posted $1.81 earnings per share. CVS Health's revenue for the quarter was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Analysts expect that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd will be paid a $0.6650 dividend. This represents a $2.66 annualized dividend and a dividend yield of 2.9%. The ex-dividend date of this dividend is Thursday, October 22nd. CVS Health's payout ratio is currently 70.37%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on CVS shares. Argus boosted their price objective on shares of CVS Health from $104.00 to $114.00 and gave the company a "buy" rating in a research report on Wednesday, August 19th. Wells Fargo & Company raised their target price on shares of CVS Health from $103.00 to $123.00 and gave the stock an "overweight" rating in a research report on Monday, July 13th. Piper Sandler set a $112.00 target price on shares of CVS Health in a research note on Wednesday, September 9th. Wall Street Zen downgraded CVS Health from a "strong-buy" rating to a "buy" rating in a report on Monday, October 19th. Finally, Truist Financial boosted their price target on CVS Health from $108.00 to $118.00 and gave the company a "buy" rating in a report on Tuesday, July 14th. Twenty investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $107.80.

Key CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS is expected to benefit from a recovery in Aetna’s margins and continued earnings improvement. Its full-year 2026 outlook calls for EPS of approximately $7.90–$8.10, supporting the view that profitability is recovering after several difficult years. Should You Buy CVS Health Stock While It's Under $100?
• Positive Sentiment: The company is expanding its retail assortment to include more Pokémon products, collectibles, toys and seasonal merchandise. Management expects adult demand for collectibles to create additional front-store sales opportunities. CVS wants to sell more Pokémon, collectibles
• Neutral Sentiment: Investors are awaiting CVS’s third-quarter 2026 report. Aetna margin recovery and digital investments could support results, but the company continues to face 340B-related pressure and declining membership, making the earnings outlook mixed. CVS Health Q3 Earnings Preview
• Neutral Sentiment: A shareholder-law firm is soliciting CVS investors regarding potential breaches of fiduciary duties. The notice does not establish wrongdoing, but it could add headline and litigation risk. Shareholder fiduciary-duty inquiry
• Negative Sentiment: CVS pharmacy workers in Rhode Island rallied over staffing and contract issues, highlighting potential labor disruption, wage pressure and service-quality concerns. CVS workers in Rhode Island rally
• Negative Sentiment: Health insurers are challenging Medicaid rating requirements in Georgia. Any unfavorable outcome could increase compliance costs or pressure reimbursement economics for insurers, including CVS’s Aetna business. Georgia Medicaid rating challenges

CVS Health Company Profile

CVS Health Corporation NYSE: CVS is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company's Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.